Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-13

Clinical Trial Update: TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease [NA]

View source ↗

Summary

A multicenter study (TOPIT) evaluates trough level–optimized infliximab maintenance therapy versus standard dosing in pediatric Crohn's disease to assess compar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: Klinikum Westbrandenburg GmbH | Conditions: Pediatric Crohns Disease | NA | Status: UNKNOWN